Pain Patch

SAN FRANCISCO – Settling antitrust claims with the state of California on Friday, pharmaceutical company Endo agreed to pay $760,000 and not strike deals with generic drugmakers without state approval as it did to delay a generic version of its Lidoderm pain patch in 2012.

%d bloggers like this: